Procept secures FDA IDE for Aquablation and completes WATER IV study enrolment
Procept BioRobotics anticipates sharing the primary endpoint results from WATER IV in 2027.
Educating the medical device manufacturing industry since 2002.
Procept BioRobotics anticipates sharing the primary endpoint results from WATER IV in 2027.
To track and verify embodied emissions through every stage of the supply chain, leading OEMs are piloting blockchain-anchored digital product passports (DPPs). Ellie Philpotts talks to Chris Taylor, sustainability lead...
Go with the flow
Harnessing automation
How smart can it be?
Killer nanopatterns